Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bliss

Showing results (211-220 of 378) with videos related to

Pageof 38
Sort By:
Health Physics|October 13, 2009
Results of a self-absorption study on the Versapor 3000 47-mm filters for radioactive particulate air stack samplingJ M Barnett, V I Cullinan, D S Barnett, et al.
Trials|May 7, 2022
Operational complexity versus design efficiency: challenges of implementing a phase IIa multiple parallel cohort targeted treatment platform trial in advanced breast cancerClaire Snowdon, Sarah Kernaghan, Laura Moretti, et al.
NPJ Breast Cancer|February 13, 2021
Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapiesJohn F R Robertson, Angelo Di Leo, Stephen Johnston, et al.
European Thyroid Journal|September 5, 2017
TPOAb and Thyroid Function Are Not Associated with Breast Cancer Outcome: Evidence from a Large-Scale Study Using Data from the Taxotere as Adjuvant Chemotherapy Trial (TACT, CRUK01/001)Ilaria Muller, Lucy S Kilburn, Peter N Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2006
Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancerLesley J Fallowfield, Judith M Bliss, Lucy S Porter, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 27, 2008
Evaluation of a method for grading late photographic change in breast appearance after radiotherapy for early breast cancerJ S Haviland, A Ashton, B Broad, et al.
Molecular and Cellular Neurosciences|October 20, 2009
Regulated expression of the Ras effector Rin1 in forebrain neuronsBartholomew Dzudzor, Lucia Huynh, Minh Thai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2018
Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled TrialIndrani S Bhattacharya, Joanne S Haviland, Anna M Kirby, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Randomised trial of epirubicin versus fluorouracil in advanced gastric cancer. An International Collaborative Cancer Group (ICCG) studyR C Coombes, C E Chilvers, D Amadori, et al.
Contemporary Clinical Trials Communications|December 3, 2019
Biomarker-guided trials: Challenges in practiceM Antoniou, R Kolamunnage-Dona, J Wason, et al.
Pageof 38

Showing results (211-220 of 378) with videos related to

Sort By:
Pageof 38
Health Physics|October 13, 2009
Results of a self-absorption study on the Versapor 3000 47-mm filters for radioactive particulate air stack samplingJ M Barnett, V I Cullinan, D S Barnett, et al.
Trials|May 7, 2022
Operational complexity versus design efficiency: challenges of implementing a phase IIa multiple parallel cohort targeted treatment platform trial in advanced breast cancerClaire Snowdon, Sarah Kernaghan, Laura Moretti, et al.
NPJ Breast Cancer|February 13, 2021
Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapiesJohn F R Robertson, Angelo Di Leo, Stephen Johnston, et al.
European Thyroid Journal|September 5, 2017
TPOAb and Thyroid Function Are Not Associated with Breast Cancer Outcome: Evidence from a Large-Scale Study Using Data from the Taxotere as Adjuvant Chemotherapy Trial (TACT, CRUK01/001)Ilaria Muller, Lucy S Kilburn, Peter N Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2006
Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancerLesley J Fallowfield, Judith M Bliss, Lucy S Porter, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 27, 2008
Evaluation of a method for grading late photographic change in breast appearance after radiotherapy for early breast cancerJ S Haviland, A Ashton, B Broad, et al.
Molecular and Cellular Neurosciences|October 20, 2009
Regulated expression of the Ras effector Rin1 in forebrain neuronsBartholomew Dzudzor, Lucia Huynh, Minh Thai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2018
Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled TrialIndrani S Bhattacharya, Joanne S Haviland, Anna M Kirby, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Randomised trial of epirubicin versus fluorouracil in advanced gastric cancer. An International Collaborative Cancer Group (ICCG) studyR C Coombes, C E Chilvers, D Amadori, et al.
Contemporary Clinical Trials Communications|December 3, 2019
Biomarker-guided trials: Challenges in practiceM Antoniou, R Kolamunnage-Dona, J Wason, et al.
Pageof 38